Results 331 to 340 of about 318,338 (358)

DNA-PKcs, but not TLR9, is required for activation of Akt by CpG-DNA

EMBO Journal, 2005
Ana-Maria Dragoi, Stanimir S Ivanov, Dianqing Wu   +2 more
exaly  

Tumor‐Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel‐Enhanced Immunotherapy with Polarization toward M1‐Type Macrophages on Triple Negative Breast Cancers

Advanced Materials, 2019
Lv Chen, Yonglin Lu, Bin Liu
exaly  

Nanoscale Zeolitic Imidazolate Framework-8 as Efficient Vehicles for Enhanced Delivery of CpG Oligodeoxynucleotides

ACS Applied Materials & Interfaces, 2017
Huijie Zhang, Jinghua Chen
exaly  

Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres

Journal of Controlled Release, 2002
Manish Diwan, Mohsen Tafaghodi, John Samuel   +2 more
exaly  

CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases

Advanced Drug Delivery Reviews, 2009
Dennis M Klinman, Takashi Sato
exaly  

CpG

2005
openaire   +1 more source

CpG Islands

2013
M. Jung, G.P. Pfeifer
openaire   +1 more source

Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cells

European Journal of Immunology, 2001
Anne Krug, Simon Rothenfusser, Veit Hornung   +2 more
exaly  

CpG Oligodeoxynucleotides

2001
Joel N. Kline, Arthur M. Krieg
openaire   +1 more source

CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation

EMBO Journal, 1998
Hans Hacker, Harald Mischak, Thomas Miethke   +2 more
exaly